Racial and ethnic differences in survival in contemporary metastatic renal cell carcinoma patients, according to alternative treatment modalities
Language English Country Netherlands Media print-electronic
Document type Comparative Study, Journal Article
PubMed
31993859
DOI
10.1007/s10552-020-01270-8
PII: 10.1007/s10552-020-01270-8
Knihovny.cz E-resources
- Keywords
- African-American, Caucasian, Cytoreductive nephrectomy, Hispanic, Metastatic renal cell carcinoma, Systemic therapy,
- MeSH
- White People statistics & numerical data MeSH
- Black or African American statistics & numerical data MeSH
- Hispanic or Latino statistics & numerical data MeSH
- Carcinoma, Renal Cell ethnology mortality pathology therapy MeSH
- Kidney pathology MeSH
- Middle Aged MeSH
- Humans MeSH
- Neoplasm Metastasis MeSH
- Survival Rate MeSH
- Kidney Neoplasms ethnology mortality pathology therapy MeSH
- Proportional Hazards Models MeSH
- Aged MeSH
- Check Tag
- Middle Aged MeSH
- Humans MeSH
- Male MeSH
- Aged MeSH
- Female MeSH
- Publication type
- Journal Article MeSH
- Comparative Study MeSH
- Geographicals
- Italy epidemiology MeSH
PURPOSE: To test the association between African-American race and overall mortality (OM) rates in patients with metastatic renal cell carcinoma (mRCC). METHODS: Within the Surveillance, Epidemiology, and End Results registry (2006-2015), we identified patients with clear cell (ccmRCC) and non-clear cell mRCC (non-ccmRCC). African-Americans, Caucasians, and Hispanics were identified. Stratification was made according to histology and treatments: (1) no treatment, (2) systemic therapy (ST), (3) cytoreductive nephrectomy (CNT), (4) CNT + ST. Kaplan-Meier plots and multivariable Cox regression analyses were used. RESULTS: Of ccmRCC patients, 410 (7%), 4353 (75%), and 1005 (17%) were African-American, Caucasian, and Hispanic, respectively. Of non-ccmRCC patients, 183 (25%), 479 (65%), and 77 (10%) were African-American, Caucasian, and Hispanic, respectively. In ccmRCC, African-Americans were associated with higher OM rates (HR 1.20; 95% CI 1.05-1.37). Conversely, in non-ccmRCC, African-Americans were associated with lower OM rates (HR 0.75; 95% CI 0.59-0.97). CONCLUSION: African-American race is associated with prolonged survival in non-ccmRCC, but it is also associated with lower survival rates in ccmRCC. The exception to these observations consisted of patients treated with combination of CNT + ST for either ccmRCC or non-ccmRCC.
Academic Department of Urology IRCCS Policlinico San Donato University of Milan Milan Italy
Department of Oncology and Hemato Oncology University of Milan Milan Italy
Department of Urology 2nd Faculty of Medicine Charles University Prag Czech Republic
Department of Urology Comprehensive Cancer Center Medical University of Vienna Vienna Austria
Department of Urology San Luigi Gonzaga Hospital University of Turin Turin Italy
Department of Urology University of Texas Southwestern Dallas TX USA
Departments of Urology Weill Cornell Medical College New York NY USA
Martini Klinik Prostate Cancer Center University Hospital Hamburg Eppendorf Hamburg Germany
References provided by Crossref.org